Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2015 (2015), Article ID 179689, 6 pages
http://dx.doi.org/10.1155/2015/179689
Research Article

Anti-MUC1 Antibody in Nipple Aspirate Fluids Correlates with Tumor Aggressiveness in Breast Cancer: A Feasibility Study

1Division of Surgical Oncology, Department of Surgery, University of Pittsburgh School of Medicine, Magee-Womens Hospital of UPMC, Pittsburgh, PA 15213, USA
2Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA

Received 19 June 2015; Revised 27 October 2015; Accepted 11 November 2015

Academic Editor: Chih-Hung Ku

Copyright © 2015 Ebru Menekse et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Globocan, “Estimated cancer incidence, mortality and prevalence worldwide in 2012,” 2012, http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.
  2. National Cancer Institute, “SEER Stat Fact Sheets: Breast cancer,” http://seer.cancer.gov/statfacts/html/breast.html.
  3. R. de Gelder, E. A. M. Heijnsdijk, J. Fracheboud, G. Draisma, and H. J. de Koning, “The effects of population-based mammography screening starting between age 40 and 50 in the presence of adjuvant systemic therapy,” International Journal of Cancer, vol. 137, no. 1, pp. 165–172, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. D. W. Kufe, “MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches,” Oncogene, vol. 32, no. 9, pp. 1073–1081, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Brayman, A. Thathiah, and D. D. Carson, “MUC1: a multifunctional cell surface component of reproductive tissue epithelia,” Reproductive Biology and Endocrinology, vol. 2, article 4, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. P. L. Beatty and O. J. Finn, “Preventing cancer by targeting abnormally expressed self-antigens: MUC1 vaccines for prevention of epithelial adenocarcinomas,” Annals of the New York Academy of Sciences, vol. 1284, no. 1, pp. 52–56, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Von Mensdorff-Pouilly, M. Moreno, and R. H. M. Verheijen, “Natural and induced humoral responses to MUC1,” Cancers, vol. 3, no. 3, pp. 3073–3103, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. S. E. Baldus and F.-G. Hanisch, “Biochemistry and pathological importance of mucin-associated antigens in gastrointestinal neoplasia,” Advances in Cancer Research, vol. 79, pp. 201–248, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. J. J. Rahn, L. Dabbagh, M. Pasdar, and J. C. Hugh, “The importance of MUC1 cellular localization in patients with breast carcinoma: an immunohistologic study of 71 patients and review of the literature,” Cancer, vol. 91, no. 11, pp. 1973–1982, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. S. J. Gendler, “MUC1, the renaissance molecule,” Journal of Mammary Gland Biology and Neoplasia, vol. 6, no. 3, pp. 339–353, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Yang, X. F. Hu, and P. X. Xing, “Advances of MUC1 as a target for breast cancer immunotherapy,” Histology and Histopathology, vol. 22, no. 8, pp. 905–922, 2007. View at Google Scholar · View at Scopus
  12. S. von Mensdorff-Pouilly, A. A. Verstraeten, P. Kenemans et al., “Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin,” Journal of Clinical Oncology, vol. 18, no. 3, pp. 574–583, 2000. View at Google Scholar · View at Scopus
  13. P. Klein, E. Glaser, L. Grogan et al., “Biomarker assays in nipple aspirate fluid,” Breast Journal, vol. 7, no. 6, pp. 378–387, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. P. M. Klein and J. A. Lawrence, “Lavage and nipple aspiration of breast ductal fluids: a source of biomarkers for environmental mutagenesis,” Environmental and Molecular Mutagenesis, vol. 39, no. 2-3, pp. 127–133, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Mannello, V. Medda, and G. A. Tonti, “Protein profile analysis of the breast microenvironment to differentiate healthy women from breast cancer patients,” Expert Review of Proteomics, vol. 6, no. 1, pp. 43–60, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. H. M. Kuerer, P. A. Thompson, S. Krishnamurthy et al., “High and differential expression of HER-2/neu extracellular domain in bilateral ductal fluids from women with unilateral invasive breast cancer,” Clinical Cancer Research, vol. 9, no. 2, pp. 601–605, 2003. View at Google Scholar · View at Scopus
  17. J. E. Lang and H. M. Kuerer, “Breast ductal secretions: clinical features, potential uses, and possible applications,” Cancer Control, vol. 14, no. 4, pp. 350–359, 2007. View at Google Scholar · View at Scopus
  18. F. Mannello, “Analysis of the intraductal microenvironment for the early diagnosis of breast cancer: identification of biomarkers in nipple-aspirate fluids,” Expert Opinion on Medical Diagnostics, vol. 2, no. 11, pp. 1221–1231, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. D. W. Cramer, L. Titus-Ernstoff, J. R. McKolanis et al., “Conditions associated with antibodies against the tumor-associated antigen MUC1 and their relationship to risk for ovarian cancer,” Cancer Epidemiology, Biomarkers & Prevention, vol. 14, no. 5, pp. 1125–1131, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Kotera, J. D. Fontenot, G. Pecher, R. S. Metzgar, and O. J. Finn, “Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients,” Cancer Research, vol. 54, no. 11, pp. 2856–2860, 1994. View at Google Scholar · View at Scopus
  21. B. V. Sinn, G. von Minckwitz, C. Denkert et al., “Evaluation of Mucin-1 protein and mRNA expression as prognostic and predictive markers after neoadjuvant chemotherapy for breast cancer,” Annals of Oncology, vol. 24, no. 9, pp. 2316–2324, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. E. A. Rakha, R. W. G. Boyce, D. A. El-Rehim et al., “Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer,” Modern Pathology, vol. 18, no. 10, pp. 1295–1304, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. M. A. McGuckin, M. D. Walsh, B. G. Hohn, B. G. Ward, and R. G. Wright, “Prognostic significance of MUC1 epithelial mucin expression in breast cancer,” Human Pathology, vol. 26, no. 4, pp. 432–439, 1995. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Garbar, C. Mascaux, H. Curé, and A. Bensussan, “MUC1/CD227 immunohistochemistry in routine practice is a useful biomarker in breast cancers,” Journal of Immunoassay and Immunochemistry, vol. 34, no. 3, pp. 232–245, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. M. T. I. Larrain, A. G. Colussi, S. O. Demichelis et al., “Humoral immune response against tumoral mucin 1 (MUC1) in breast cancer patients,” The International Journal of Biological Markers, vol. 28, no. 3, pp. 318–325, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Piura and E. Piura, “Autoantibodies to tumor-associated antigens in breast carcinoma,” Journal of Oncology, vol. 2010, Article ID 264926, 14 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. S. von Mensdorff-Pouilly, M. M. Gourevitch, P. Kenemans et al., “Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumours,” European Journal of Cancer A, vol. 32, no. 8, pp. 1325–1331, 1996. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Vassilaros, A. Tsibanis, A. Tsikkinis, G. A. Pietersz, I. F. C. McKenzie, and V. Apostolopoulos, “Up to 15-year clinical follow-up of a pilot Phase III immunotherapy study in stage II breast cancer patients using oxidized mannan-MUC1,” Immunotherapy, vol. 5, no. 11, pp. 1177–1182, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. S. K. Ghosh, P. Pantazopoulos, Z. Medarova, and A. Moore, “Expression of underglycosylated MUC1 antigen in cancerous and adjacent normal breast tissues,” Clinical Breast Cancer, vol. 13, no. 2, pp. 109–118, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Tang, L. Wang, P. Zhang et al., “Detection of circulating anti-mucin 1 (MUC1) antibodies in breast tumor patients by indirect enzyme-linked immunosorbent assay using a recombinant MUC1 protein containing six tandem repeats and expressed in Escherichia coli,” Clinical and Vaccine Immunology, vol. 17, no. 12, pp. 1903–1908, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. M. V. Croce, M. T. Isla-Larrain, M. R. Price, and A. Segal-Eiras, “Detection of circulating mammary mucin (MUC1) and MUC1 immune complexes (MUC1-CIC) in healthy women,” The International Journal of Biological Markers, vol. 16, no. 2, pp. 112–120, 2001. View at Google Scholar · View at Scopus